Pointerra Limited (ASX:3DP)

Theseus Pharmaceuticals Statistics

Total Valuation

Pointerra has a market cap or net worth of AUD 35.29 million. The enterprise value is 31.05 million.

Market Cap	35.29M
Enterprise Value	31.05M

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Pointerra has 750.78 million shares outstanding. The number of shares has increased by 10.55% in one year.

Current Share Class	750.78M
Shares Outstanding	750.78M
Shares Change (YoY)	+10.55%
Shares Change (QoQ)	+7.99%
Owned by Insiders (%)	23.83%
Owned by Institutions (%)	n/a
Float	486.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	8.25
PS Ratio	3.22
PB Ratio	60.77
P/TBV Ratio	66.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 55.72, with an EV/FCF ratio of -858.33.

EV / Earnings	-4,568.86
EV / Sales	2.83
EV / EBITDA	55.72
EV / EBIT	72.75
EV / FCF	-858.33

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.64.

Current Ratio	1.12
Quick Ratio	1.08
Debt / Equity	0.64
Debt / EBITDA	0.67
Debt / FCF	-10.35
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	6.82%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	47.04%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	2.80
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.49% in the last 52 weeks. The beta is 1.58, so Pointerra's price volatility has been higher than the market average.

Beta (5Y)	1.58
52-Week Price Change	-36.49%
50-Day Moving Average	0.05
200-Day Moving Average	0.06
Relative Strength Index (RSI)	35.65
Average Volume (20 Days)	752,726

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pointerra had revenue of AUD 10.96 million and -6,797 in losses. Loss per share was -0.00.

Revenue	10.96M
Gross Profit	4.24M
Operating Income	426,869
Pretax Income	-6,797
Net Income	-6,797
EBITDA	505,272
EBIT	426,869
Loss Per Share	-0.00

Balance Sheet

The company has 4.61 million in cash and 374,361 in debt, giving a net cash position of 4.23 million or 0.01 per share.

Cash & Cash Equivalents	4.61M
Total Debt	374,361
Net Cash	4.23M
Net Cash Per Share	0.01
Equity (Book Value)	580,664
Book Value Per Share	0.00
Working Capital	515,445

Cash Flow

In the last 12 months, operating cash flow was -20,225 and capital expenditures -15,955, giving a free cash flow of -36,180.

Operating Cash Flow	-20,225
Capital Expenditures	-15,955
Free Cash Flow	-36,180
FCF Per Share	-0.00

Margins

Gross margin is 38.72%, with operating and profit margins of 3.90% and -0.06%.

Gross Margin	38.72%
Operating Margin	3.90%
Pretax Margin	-0.06%
Profit Margin	-0.06%
EBITDA Margin	4.61%
EBIT Margin	3.90%
FCF Margin	n/a

Dividends & Yields

Pointerra does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.55%
Shareholder Yield	n/a
Earnings Yield	-0.02%
FCF Yield	-0.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pointerra has an Altman Z-Score of 0.89 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.89
Piotroski F-Score	4